Acute radiation syndrome: An update on biomarkers for radiation injury

• Published in: Journal of radiation and cancer research Vol. 9; no. 4; pp. 132 - 146
• Main Authors: Singh, Vijay, Santiago, Paola, Simas, Madison, Garcia, Melissa, Fatanmi, Oluseyi, Wise, Stephen, Seed, Thomas
• Format: Journal Article
• Language: English
• Published: Wolters Kluwer India Pvt. Ltd 01-01-2018; Wolters Kluwer Medknow Publications
• Subjects: Acute radiation syndrome; animal rule; biomarkers; chromosomal aberration; irradiation; mice; nonhuman primates; omics; omics; biomarkers; Acute radiation syndrome; animal rule; chromosomal aberration; nonhuman primates; mice; irradiation
• ISSN: 2588-9273; 2468-9203
• DOI: 10.4103/jrcr.jrcr_26_18

The possible detonation of a radiological dispersal device or improvised nuclear device in a metropolitan city, or the accidental exposures to a radiation source, nuclear accidents, or the all-to-often threats of radiological/nuclear terrorism have led to the urgent need to develop essential analytic tools to assess such radiation exposures, especially radiation doses to exposed individuals. This exposure-assessing work using biological samples, and discipline, is known as biodosimetry. As of late, this field has progressed significantly as it has made use of the advances within newer areas of biologic analytics, namely omics (genomics, proteomics, metabolomics, and transcriptomics), lymphocyte kinetics, optically stimulated luminescence, and electron paramagnetic resonance technology in addition to conventional cytogenetic techniques. The use of automated high throughput platforms and the planning for laboratory surge capacity during the time of need are the latest developments in the field of biomarkers for biodosimetry. Such biomarkers are also needed for radiation exposure/dose conversion estimates that are essential for the development and application of radiation countermeasures, from animals to humans and that are currently being developed following the US Food and Drug Administration Animal Rule. Here, we present and discuss the current status of various biomarkers for assessing radiation dose after radiation exposure. It is anticipated that with the advent of improved biomarkers and associated biomarker platforms for the acute radiation syndrome, exposed victims can be more efficiently triaged and appropriately treated than is currently allowable. The latest advances in the field, and identify the areas where improvement is needed are also listed and discussed.